Compassionate study to evaluate the efficacy of Brentuximab Vedotin in patients with relapsed or refractory peripheral T-Cell lymphoma.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 19 Dec 2015
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications T cell lymphoma
- Focus Expanded access; Therapeutic Use
- 19 Dec 2015 New trial record